Piccole molecole di interesse farmaceutico

 
 
Richiedi informazioni

Prodotti e servizi di elevata qualità


Sviluppare un nuovo farmaco è un processo complesso ed impegnativo. Azienda leader nella fornitura di prodotti e servizi di elevata qualità alle aziende chimiche e farmaceutiche, Merck Millipore offre tutto quello che serve per ottimizzarne lo sviluppo e ridurne il tempo necessario per la commercializzazione.

Con i nostri esaurienti dossier EMPROVE® forniamo documentazione dettagliata e specifica a seconda dell'impiego per una gamma in continua crescita di materie prime farmaceutiche, a vantaggio della sicurezza e di un considerevole risparmio di tempo e costi.
  • Un portafoglio continuamente aggiornato in risposta a mercati e requisiti legislativi in continua evoluzione
  • Un'ampia gamma di servizi con il Cliente al centro
  • Produzione di quantitativi personalizzati su scala globale
  • Esperienza ed attrezzature d'avanguardia si aggiungono ad una matrice completa di tecnologie di produzione in grado di portare a termine oltre il 95% delle comuni reazioni chimiche
  • Assistenza completa attraverso l'intera catena dello sviluppo per quanto riguarda gli aspetti chimici ed anche quelli normativi
  • Siti di sviluppo e produttivi certificati cGMP e ispezionati dall'FDA

Comunicati stampa

18-apr-2018
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
17-apr-2018
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing

Merck today introduced three new products to support flexible manufacturing of biologics.

20180417
12-apr-2018
Merck Helps Accelerate Global Access to Affordable Vaccines

Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
28-mar-2018
Merck Named Best Bioprocessing Supplier in Asia

Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
05-mar-2018
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
27-feb-2018
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

Merck today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
26-feb-2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
22-feb-2018
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre

Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
22-feb-2018
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
22-feb-2018
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi

Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
20-feb-2018
Merck Receives Two More Patents for CRISPR Technology

Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.

20180220 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
13-feb-2018
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica
Visualizza tutte le notizie
 
Webinar:  API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Webinar:
API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Register Now
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Webinar:
Successful Drug Development with Synthetic Lipids:
Critical Aspects and
Strategies

Watch Now
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!

Eventi